Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q1 2021 · 10-Q
Revenue$5.01M$5.01M−22.8% vs Q1 2020 Net Income-$1.18M-$1.18MN/M vs Q1 2020 EPS Diluted-$0.17-$0.17N/M vs Q1 2020 Gross Profit$4,535,003+42.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flow-$1,261,604N/M Free Cash Flowderived-$1,265,995N/M Margins · derivedGross margin90.5%+41.3 pt vs Q1 2020
Operating margin-21.6%+6.0 pt vs Q1 2020
Net margin-23.6%+4.7 pt vs Q1 2020
ended Mar 31, 2021 · filed May 14, 2021 · 44 d after period end